William A. Curran

Davis Polk is advising Aetna on its approximately $77 billion acquisition by CVS Health. The transaction, which is expected to close in the second half of 2018, is subject to approval by…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by SRC Energy Inc. of $550 million aggregate principal amount of 6…

Davis Polk advised the representatives of the several underwriters in connection with Bandwidth Inc.’s initial public offering of 4,000,000 shares of Class A common stock, at $20.00…

Davis Polk advised the joint book-running managers in connection with an SEC-registered common stock offering of 40,250,000 shares of common stock of SRC Energy, Inc. Included in the…

Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…

Davis Polk advised Auris Medical Holding AG in connection with the SEC-registered offering of $1.5 million of its common shares to Lincoln Park Capital Fund, LLC. The common shares are…

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…

Davis Polk advised the joint book-running managers in connection with the initial public offering of 40,250,000 units of Capitol Investment Corp. IV, including 5,250,000 units…

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $2.75 billion aggregate principal amount of senior notes in four series, consisting of $300 million…

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $200 million SEC-registered follow-on offering of 50,000,000 shares of common…